RODERICK JACK RAY
Pilots at Butler Market Rd, Bend, OR
License number
Oregon A2474020
Issued Date
Feb 2015
Expiration Date
Feb 2016
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
21621 NE Butler Market Rd, Bend, OR 97701
Personal information
See more information about RODERICK JACK RAY at radaris.comName
Address
Phone
21621 NE Butler Market Rd, Bend, OR 97701
21621 Butler Market Rd, Bend, OR 97701
Professional information
Selective Aqueous Extraction Of Organics Coupled With Trapping By Membrane Separation
US Patent:
5041227, Aug 20, 1991
Filed:
Oct 9, 1990
Appl. No.:
7/595241
Inventors:
Paul van Eikeren - Bend OR
Daniel J. Brose - Bend OR
Roderick J. Ray - Bend OR
Daniel J. Brose - Bend OR
Roderick J. Ray - Bend OR
Assignee:
Bend Research, Inc.
International Classification:
B01D 6100
US Classification:
210640
Abstract:
An improvement to processes for the selective extractation of organic solutes from organic solvents by water-based extractants is disclosed, the improvement comprising coupling various membrane separation processes with the organic extraction process, the membrane separation process being utilized to continuously recycle the water-based extractant and at the same time selectively remove or concentrate organic solute from the water-based extractant.
Method For Making Homogeneous Spray-Dried Solid Amorphous Drug Dispersions Using Pressure Nozzles
US Patent:
7780988, Aug 24, 2010
Filed:
Jan 24, 2003
Appl. No.:
10/351568
Inventors:
Ronald A. Beyerinck - Bend OR, US
Roderick J. Ray - Bend OR, US
Dan E. Dobry - Bend OR, US
Dana M. Settell - Bend OR, US
Roderick J. Ray - Bend OR, US
Dan E. Dobry - Bend OR, US
Dana M. Settell - Bend OR, US
Assignee:
Bend Research, Inc. - Bend OR
International Classification:
A61K 9/14, B29B 9/00
US Classification:
424489, 264 5
Abstract:
Homogeneous solid amorphous dispersions of drugs in concentration-enhancing polymers are formed in desirable larger particle sizes with minimal fines by using an atomizer and process conditions capable of producing droplets having an average diameter of at least 50 microns and a Dof at least 10 microns.
Controlled Release Multiparticulates Formed With Dissolution Enhancers
US Patent:
2005015, Jul 14, 2005
Filed:
Dec 3, 2004
Appl. No.:
11/003853
Inventors:
Leah Appel - Bend OR, US
Roderick Ray - Bend OR, US
David Newbold - Bend OR, US
David Lyon - Bend OR, US
James West - Bend OR, US
Dwayne Friesen - Bend OR, US
Scott McCray - Bend OR, US
Marshall Crew - Bend OR, US
Julian Lo - Old Lyme CT, US
Roderick Ray - Bend OR, US
David Newbold - Bend OR, US
David Lyon - Bend OR, US
James West - Bend OR, US
Dwayne Friesen - Bend OR, US
Scott McCray - Bend OR, US
Marshall Crew - Bend OR, US
Julian Lo - Old Lyme CT, US
International Classification:
A61K031/7052, A61K009/22, A61K009/14
US Classification:
424489000, 514028000
Abstract:
Pharmaceutical compositions of crystalline azithromycin-containing multiparticulates having low concentrations of azithromycin ester degradants and exhibiting controlled release of the drug are achieved by inclusion of dissolution enhancers having low concentrations of acid and ester substituents.
Hybrid Membrane Separation Systems
US Patent:
4944882, Jul 31, 1990
Filed:
Apr 21, 1989
Appl. No.:
7/341646
Inventors:
Roderick J. Ray - Bend OR
David D. Newbold - Bend OR
David D. Newbold - Bend OR
Assignee:
Bend Research, Inc. - Bend OR
International Classification:
B01D 1300
US Classification:
210640
Abstract:
Hybrid membrane-based separation systems are disclosed that are useful in separating solvents and solutes. The hybrid systems combine any of the solvent removal processes reverse osmosis, nanofiltration, membrane distillation and pervaporation with any one of more of the solute removal processes utilizing pervaporation membranes, supported-liquid membranes, coupled transport membranes, and membrane contactors, the solvent and solute removal processes forming part of a recycle stream that utilizes membrane separation retentates as feeds and as recycle feed stream make-up.
Fast-Disintegrating Microporous Binders
US Patent:
2008013, Jun 12, 2008
Filed:
Jan 17, 2006
Appl. No.:
11/814501
Inventors:
Roderick Jack Ray - Bend OR, US
Dwayne Thomas Friesen - Bend OR, US
Marshall David Crew - Bend OR, US
Richard Frank Falk - Bend OR, US
Sanjay Konagurthu - Bend OR, US
Dwayne Thomas Friesen - Bend OR, US
Marshall David Crew - Bend OR, US
Richard Frank Falk - Bend OR, US
Sanjay Konagurthu - Bend OR, US
International Classification:
A61K 9/16, A61K 47/38
US Classification:
424494, 514781
Abstract:
A highly porous, fast-disintegrating binder suitable for pharmaceutical applications and methods of making the same are disclosed, the binder comprising microporous particles of an aqueous-soluble cellulosic polymer and a wicking agent. Pharmaceutical compositions and fast-disintegrating dosage forms containing the binder are also disclosed.
Multiparticulate Crystalline Drug Compositions Having Controlled Release Profiles
US Patent:
7887844, Feb 15, 2011
Filed:
Dec 3, 2004
Appl. No.:
11/004168
Inventors:
Leah E. Appel - Bend OR, US
Roderick J. Ray - Bend OR, US
David K. Lyon - Bend OR, US
James B. West - Bend OR, US
Scott B. McCray - Bend OR, US
Marshall D. Crew - Bend OR, US
Dwayne T. Friesen - Bend OR, US
Scott M. Herbig - East Lyme CT, US
Julian B. Lo - Old Lyme CT, US
Roderick J. Ray - Bend OR, US
David K. Lyon - Bend OR, US
James B. West - Bend OR, US
Scott B. McCray - Bend OR, US
Marshall D. Crew - Bend OR, US
Dwayne T. Friesen - Bend OR, US
Scott M. Herbig - East Lyme CT, US
Julian B. Lo - Old Lyme CT, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 9/14, A61K 9/16
US Classification:
424489, 424490
Abstract:
A multiparticulate for controlled release of a drug comprises crystalline drug, a glyceride having at least one alkylate substituent of at least 16 carbon atoms, and a poloxamer, wherein at least 70 wt % of the drug in the multiparticulate is crystalline.
Solvent Resistant Hollow Fiber Vapor Permeation Membranes And Modules
US Patent:
5753008, May 19, 1998
Filed:
Jul 12, 1995
Appl. No.:
8/501403
Inventors:
Dwayne T. Friesen - Bend OR
Scott B. McCray - Bend OR
David D. Newbold - Bend OR
Roderick J. Ray - Bend OR
Scott B. McCray - Bend OR
David D. Newbold - Bend OR
Roderick J. Ray - Bend OR
Assignee:
Bend Research, Inc. - Bend OR
International Classification:
B01D 5322, B01D 6908, B01D 6136
US Classification:
95 45
Abstract:
A vapor permeation method and apparatus for removing a vapor from a vaporous feed stream, the method and apparatus utilizing highly solvent-resistant composite hollow fiber membranes and a permeate flow countercurrent to the feed flow, wherein the support of the composite membrane is formed by solution casting and has been rendered sufficiently solvent-resistant by a post-casting step to retain at least 20 of its burst pressure when soaked in the solvent used to cast the support.
Vapor Permeation System
US Patent:
5843209, Dec 1, 1998
Filed:
Aug 13, 1997
Appl. No.:
8/910409
Inventors:
Roderick J. Ray - Bend OR
David D. Newbold - Bend OR
Dwayne T. Friesen - Bend OR
Scott B. McCray - Bend OR
David D. Newbold - Bend OR
Dwayne T. Friesen - Bend OR
Scott B. McCray - Bend OR
Assignee:
Bend Research, Inc. - Bend OR
International Classification:
B01D 5322
US Classification:
95 52
Abstract:
Membrane-based vapor permeation system for selective removal of a vapor from a fluid feed stream, wherein a countercurrent sweep stream is used that has a particular partial pressure of the vapor to be removed.
Multiparticulate Compositions With Improved Stability
US Patent:
7736672, Jun 15, 2010
Filed:
Dec 3, 2004
Appl. No.:
11/003664
Inventors:
Roderick J. Ray - Bend OR, US
Leah E. Appel - Bend OR, US
Dwayne Thomas Friesen - Bend OR, US
Marshall D. Crew - Bend OR, US
Joshua R. Shockey - Bend OR, US
Leah E. Appel - Bend OR, US
Dwayne Thomas Friesen - Bend OR, US
Marshall D. Crew - Bend OR, US
Joshua R. Shockey - Bend OR, US
Assignee:
Pfizer, Inc. - New York NY
International Classification:
A61K 9/14
US Classification:
424489
Abstract:
A process is described for producing drug-containing multiparticulates with improved stability, characterized by an improvement in one or more of chemical stability, physical stability, or dissolution stability.
Azithromycin Multiparticulate Dosage Forms By Melt-Congeal Processes
US Patent:
2005015, Jul 21, 2005
Filed:
Dec 3, 2004
Appl. No.:
11/003856
Inventors:
Leah Appel - Bend OR, US
Roderick Ray - Bend OR, US
David Newbold - Bend OR, US
Dwayne Freisen - Bend OR, US
Scott McCray - Bend OR, US
James West - Bend OR, US
David Lyon - Bend OR, US
Marshall Crew - Bend OR, US
Steven Lemott - East Lyme CT, US
Scott Herbig - East Lyme CT, US
Julian Lo - Old Lyme CT, US
Roderick Ray - Bend OR, US
David Newbold - Bend OR, US
Dwayne Freisen - Bend OR, US
Scott McCray - Bend OR, US
James West - Bend OR, US
David Lyon - Bend OR, US
Marshall Crew - Bend OR, US
Steven Lemott - East Lyme CT, US
Scott Herbig - East Lyme CT, US
Julian Lo - Old Lyme CT, US
International Classification:
A61K009/52, A61K009/14, B29B009/00, A61K031/7052
US Classification:
424489000, 264005000, 514028000
Abstract:
Azithromycin multiparticulates containing acceptably low concentrations of azithromycin esters are formed by a melt-congeal process.